Semaglutide use before single-level lumbar fusion associated with fewer readmissions and 90-day costs.
Saved in:
| Title: | Semaglutide use before single-level lumbar fusion associated with fewer readmissions and 90-day costs. |
|---|---|
| Authors: | Ng, Mitchell K.1 (AUTHOR), Mastrokostas, Paul G.1,2 (AUTHOR) pmastrokostas06@gmail.com, Rodriguez, Ariel N.1 (AUTHOR), Razi, Abigail1,3 (AUTHOR), Mastrokostas, Leonidas E.1,2 (AUTHOR), Emara, Ahmed K.4 (AUTHOR), Ford, Brian T.5 (AUTHOR), Xu, Jacquelyn J.2 (AUTHOR), Dalton, Jonathan6 (AUTHOR), Narayanan, Rajkishen6 (AUTHOR), Kepler, Christopher K.6 (AUTHOR), Hilibrand, Alan S.6 (AUTHOR), Vaccaro, Alexander R.6 (AUTHOR), Monsef, Jad Bou1,2 (AUTHOR), Razi, Afshin E.1 (AUTHOR) |
| Source: | Journal of Craniovertebral Junction & Spine. Oct-Dec2025, Vol. 16 Issue 4, p401-407. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
